RxDoctor Payments Data

Rocksan Moss, PA

Physician Assistant · Hinesville, GANPI 1225098510

Payments from drug & device makers

$1,912in general payments, 2019–2025

Across 81 payments — averaging $23.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axsome Therapeutics, Inc.$491
  • Vanda Pharmaceuticals Inc.$330
  • AbbVie$230
  • Alkermes, Inc.$187
  • Teva Pharmaceuticals USA, Inc.$178
  • Tris Pharma Inc$77
  • plus $418 from 13 others

What the payments were for

  • Food & beverage$1,84196%
  • Education$714%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,912 in reported general payments places this provider in the 75th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$26,974
Medicare patients
38
Services billed
373

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl20$34,406
RexultiBrexpiprazole17$26,007
TrintellixVortioxetine Hydrobromide27$23,547
Bupropion XlBupropion Hcl75$3,967
Aripiprazole58$3,685
Buspirone Hcl119$1,621
Quetiapine Fumarate91$1,521
Oxcarbazepine33$1,438
Duloxetine Hcl46$1,115
Trazodone Hcl107$902
Olanzapine OdtOlanzapine15$893
Lamotrigine81$736
Fluoxetine Hcl102$619
Ziprasidone Hcl20$563
Gabapentin38$549

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$230$34,40620 claims
Otsuka America Pharmaceutical, Inc.Rexulti$72$26,00717 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$29$23,54727 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Hinesville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →